Exelixis Inc (EXEL)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$40.50

Buy

$41.47

arrow-down$-0.51 (-1.23%)

Prices updated at 13 Dec 2025, 00:52 EST

Prices minimum 15 mins delay

Prices in USD

Exelixis Inc is a biotechnology company. It is involved in discovery, development, and commercialization of new medicines for people with cancer. The Cabometyx product generates maximum revenue for the company.

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$41.79 - $40.66
	$49.62 - $31.90
	-
	10,960.42m
	17.18
	-
	2,569,223
	5.07
	2,896,804.80
	0.46
	281.73m
	US30161Q1040
	2.38
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.